BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 19859993)

  • 1. Steatosis and insulin resistance in hepatitis C: a way out for the virus?
    Del Campo JA; Romero-Gómez M
    World J Gastroenterol; 2009 Oct; 15(40):5014-9. PubMed ID: 19859993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming Growth Factor β Acts as a Regulatory Molecule for Lipogenic Pathways among Hepatitis C Virus Genotype-Specific Infections.
    Patra T; Sasaki R; Meyer K; Ray RB; Ray R
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31243135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus core protein genotype 3a increases SOCS-7 expression through PPAR-{gamma} in Huh-7 cells.
    Pazienza V; Vinciguerra M; Andriulli A; Mangia A
    J Gen Virol; 2010 Jul; 91(Pt 7):1678-86. PubMed ID: 20357037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma.
    Kim KH; Shin HJ; Kim K; Choi HM; Rhee SH; Moon HB; Kim HH; Yang US; Yu DY; Cheong J
    Gastroenterology; 2007 May; 132(5):1955-67. PubMed ID: 17484888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C.
    Castera L
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):125-34. PubMed ID: 16557184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver X receptor α-mediated regulation of lipogenesis by core and NS5A proteins contributes to HCV-induced liver steatosis and HCV replication.
    García-Mediavilla MV; Pisonero-Vaquero S; Lima-Cabello E; Benedicto I; Majano PL; Jorquera F; González-Gallego J; Sánchez-Campos S
    Lab Invest; 2012 Aug; 92(8):1191-202. PubMed ID: 22641099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms.
    Pazienza V; Clément S; Pugnale P; Conzelman S; Foti M; Mangia A; Negro F
    Hepatology; 2007 May; 45(5):1164-71. PubMed ID: 17465001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1.
    Walsh MJ; Jonsson JR; Richardson MM; Lipka GM; Purdie DM; Clouston AD; Powell EE
    Gut; 2006 Apr; 55(4):529-35. PubMed ID: 16299039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma.
    Kim KH; Hong SP; Kim K; Park MJ; Kim KJ; Cheong J
    Biochem Biophys Res Commun; 2007 Apr; 355(4):883-8. PubMed ID: 17331464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance and steatosis in chronic hepatitis C.
    Machado MV; Cortez-Pinto H
    Ann Hepatol; 2009; 8 Suppl 1():S67-75. PubMed ID: 19381127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen.
    Lonardo A; Adinolfi LE; Restivo L; Ballestri S; Romagnoli D; Baldelli E; Nascimbeni F; Loria P
    World J Gastroenterol; 2014 Jun; 20(23):7089-103. PubMed ID: 24966582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus diversity and hepatic steatosis.
    Roingeard P
    J Viral Hepat; 2013 Feb; 20(2):77-84. PubMed ID: 23301542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis.
    Piodi A; Chouteau P; Lerat H; Hézode C; Pawlotsky JM
    Hepatology; 2008 Jul; 48(1):16-27. PubMed ID: 18570290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis.
    Basaranoglu M; Basaranoglu G
    World J Gastroenterol; 2011 Sep; 17(36):4055-62. PubMed ID: 22039318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease and hepatitis C infection.
    Bondini S; Younossi ZM
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data.
    Negro F; Sanyal AJ
    Liver Int; 2009 Mar; 29 Suppl 2():26-37. PubMed ID: 19187070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of genes involved in lipogenesis is not increased in patients with HCV genotype 3 in human liver.
    Ryan MC; Desmond PV; Slavin JL; Congiu M
    J Viral Hepat; 2011 Jan; 18(1):53-60. PubMed ID: 20196803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
    Serfaty L; Capeau J
    Liver Int; 2009 Mar; 29 Suppl 2():13-25. PubMed ID: 19187069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3.
    Kawaguchi T; Yoshida T; Harada M; Hisamoto T; Nagao Y; Ide T; Taniguchi E; Kumemura H; Hanada S; Maeyama M; Baba S; Koga H; Kumashiro R; Ueno T; Ogata H; Yoshimura A; Sata M
    Am J Pathol; 2004 Nov; 165(5):1499-508. PubMed ID: 15509521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus core protein, lipid droplets and steatosis.
    Roingeard P; Hourioux C
    J Viral Hepat; 2008 Mar; 15(3):157-64. PubMed ID: 18086178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.